HALOPERIDOL TAB 1MG DIN 00587788
Health Canada record
| Active ingredient(s) | HALOPERIDOL 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AD01 HALOPERIDOL |
| Original market date | 31-Dec-1983 |
| Current status date | 13-Jul-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing HALOPERIDOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00808652 | HALOPERIDOL INJ 5MG/ML USP | SANDOZ CANADA INCORPORATED | Liquid | HALOPERIDOL 5 MG | Marketed |
| 02366010 | HALOPERIDOL INJECTION | JUNO PHARMA CANADA INC. | Solution | HALOPERIDOL 5 MG | Marketed |
| 02406411 | HALOPERIDOL INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | HALOPERIDOL 5 MG | Marketed |
| 00363677 | TEVA-HALOPERIDOL | TEVA CANADA LIMITED | Tablet | HALOPERIDOL 1 MG | Marketed |
| 00363685 | TEVA-HALOPERIDOL | TEVA CANADA LIMITED | Tablet | HALOPERIDOL 0.5 MG | Marketed |
| 00713449 | TEVA-HALOPERIDOL | TEVA CANADA LIMITED | Tablet | HALOPERIDOL 10 MG | Marketed |
| 00363650 | TEVA-HALOPERIDOL | TEVA CANADA LIMITED | Tablet | HALOPERIDOL 5 MG | Marketed |
| 00363669 | TEVA-HALOPERIDOL | TEVA CANADA LIMITED | Tablet | HALOPERIDOL 2 MG | Marketed |
| 00396818 | APO HALOPERIDOL TAB 1MG | APOTEX INC | Tablet | HALOPERIDOL 1 MG | Dormant |
| 00587702 | APO-HALOPERIDOL LIQ 2MG/ML | APOTEX INC | Solution | HALOPERIDOL 2 MG | Cancelled Post Market |
| 00463698 | APO-HALOPERIDOL TAB 10MG | APOTEX INC | Tablet | HALOPERIDOL 10 MG | Dormant |
| 00396826 | APO-HALOPERIDOL TAB 2MG | APOTEX INC | Tablet | HALOPERIDOL 2 MG | Dormant |
| 00396834 | APO-HALOPERIDOL TAB 5MG | APOTEX INC | Tablet | HALOPERIDOL 5 MG | Dormant |
| 00017574 | HALDOL INJECTION 5MG/ML | MCNEIL PHARMACEUTICAL, DIVISION OF ORTHO-MCNEIL INC. | Liquid | HALOPERIDOL 5 MG | Cancelled Post Market |
| 02540223 | HALOPERIDOL INJECTION | JUNO PHARMACEUTICALS CORP. | Solution | HALOPERIDOL 5 MG | Cancelled Pre Market |
| 02493993 | HALOPERIDOL INJECTION | NEO HEALTH CANADA INC. | Solution | HALOPERIDOL 5 MG | Cancelled (Unreturned Annual) |
| 00761745 | HALOPERIDOL TAB 2MG | PRO DOC LIMITEE | Tablet | HALOPERIDOL 2 MG | Cancelled Post Market |
| 00761753 | HALOPERIDOL TAB 5MG | PRO DOC LIMITEE | Tablet | HALOPERIDOL 5 MG | Cancelled Post Market |
| 00761761 | HALOPERIDOL-10 TAB 10MG | PRO DOC LIMITEE | Tablet | HALOPERIDOL 10 MG | Cancelled Post Market |
| 00745561 | NOVO-PERIDOL ORAL SOLN 2MG/ML | NOVOPHARM LIMITED | Solution | HALOPERIDOL 2 MG | Cancelled Post Market |
| 02239216 | NU-HALOPERIDOL | NU-PHARM INC | Tablet | HALOPERIDOL 0.5 MG | Cancelled (Unreturned Annual) |
| 02239220 | NU-HALOPERIDOL | NU-PHARM INC | Tablet | HALOPERIDOL 10 MG | Cancelled (Unreturned Annual) |
| 02239217 | NU-HALOPERIDOL | NU-PHARM INC | Tablet | HALOPERIDOL 1 MG | Cancelled (Unreturned Annual) |
| 02239218 | NU-HALOPERIDOL | NU-PHARM INC | Tablet | HALOPERIDOL 2 MG | Cancelled (Unreturned Annual) |
| 02239219 | NU-HALOPERIDOL | NU-PHARM INC | Tablet | HALOPERIDOL 5 MG | Cancelled (Unreturned Annual) |
| 00759503 | PMS-HALOPERIDOL SOLN 2MG/ML | PHARMASCIENCE INC | Solution | HALOPERIDOL 2 MG | Cancelled Post Market |
| 00552429 | RATIO-HALOPERIDOL 2MG/ML | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Solution | HALOPERIDOL 2 MG | Cancelled Post Market |
| 00728306 | RATIO-HALOPERIDOL TAB 10MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | HALOPERIDOL 10 MG | Cancelled Post Market |
| 00552143 | RATIO-HALOPERIDOL TAB 1MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | HALOPERIDOL 1 MG | Cancelled Post Market |
| 00728292 | RATIO-HALOPERIDOL TAB 2MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | HALOPERIDOL 2 MG | Cancelled Post Market |
| 00647969 | RATIO-HALOPERIDOL TAB 5MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | HALOPERIDOL 5 MG | Cancelled Post Market |
| 00768820 | TEVA-HALOPERIDOL | TEVA CANADA LIMITED | Tablet | HALOPERIDOL 20 MG | Cancelled Post Market |
International API supply for HALOPERIDOL
5 valid EDQM Certificates of Suitability from 5 holders. 13 active FDA Drug Master Files.
Request a quote for HALOPERIDOL TAB 1MG